Articles with public access mandates - Francesca DemichelisLearn more
Not available anywhere: 4
Review
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion
S Perner, JM Mosquera, F Demichelis, MD Hofer, PL Paris, J Simko, ...
The American journal of surgical pathology 31 (6), 882-888, 2007
Mandates: German Research Foundation
Review
Genetic predisposition to prostate cancer: Update and future perspectives
F Demichelis, JL Stanford
Urologic Oncology: Seminars and Original Investigations 33 (2), 75-84, 2015
Mandates: US National Institutes of Health
Review
MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples
D Romagnoli, A Nardone, F Galardi, M Paoli, F De Luca, C Biagioni, ...
Briefings in Bioinformatics, 2023
Mandates: Government of Italy
Review
1314 RECURRENT MUTATIONS IN SPOP DEFINE A DISTINCT MOLECULAR CLASS OF PROSTATE CANCER
C Barbieri, S Baca, F Demichelis, M Lawrence, M Blattner, JP Theurillat, ...
The Journal of Urology 4 (187), e532-e533, 2012
Mandates: US National Institutes of Health
Available somewhere: 127
Review
The landscape of somatic copy-number alteration across human cancers
R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ...
Nature 463 (7283), 899-905, 2010
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Review
Integrative Clinical Genomics of Advanced Prostate Cancer
D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ...
Cell 161 (5), 1215-1228, 2015
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Cancer …
Review
The molecular taxonomy of primary prostate cancer
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
Mandates: US National Institutes of Health
Review
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
CE Barbieri, SC Baca, MS Lawrence, F Demichelis, M Blattner, ...
Nature Genetics 44 (6), 685-689, 2012
Mandates: Swiss National Science Foundation, US National Institutes of Health, Howard …
Review
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ...
Nature medicine, 2016
Mandates: US National Institutes of Health, European Commission, Damon Runyon Cancer …
Review
The genomic complexity of primary human prostate cancer
MF Berger, MS Lawrence, F Demichelis, Y Drier, K Cibulskis, ...
Nature 470 (7333), 214-220, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Review
Punctuated Evolution of Prostate Cancer Genomes
SC Baca, D Prandi, MS Lawrence, JM Mosquera, A Romanel, Y Drier, ...
Cell 153 (3), 666-677, 2013
Mandates: Swiss National Science Foundation, US National Institutes of Health
Review
Genomic correlates of clinical outcome in advanced prostate cancer
W Abida, J Cyrta, G Heller, D Prandi, J Armenia, I Coleman, M Cieslik, ...
Proceedings of the National Academy of Sciences 116 (23), 11428-11436, 2019
Mandates: US Department of Defense, US National Institutes of Health, Howard Hughes …
Review
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ...
Cancer Discovery 1 (6), 487-495, 2011
Mandates: US National Institutes of Health
Review
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
P Mu, Z Zhang, M Benelli, WR Karthaus, E Hoover, CC Chen, ...
Science 355 (6320), 84-88, 2017
Mandates: US Department of Defense, US National Institutes of Health, Howard Hughes …
Review
Personalized in vitro and in vivo cancer models to guide precision medicine
C Pauli, BD Hopkins, D Prandi, R Shaw, T Fedrizzi, A Sboner, V Sailer, ...
Cancer Discovery 7 (5), 462-477, 2017
Mandates: Swiss National Science Foundation, US Department of Defense, US National …
Review
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F Demichelis, K Fall, S Perner, O Andrén, F Schmidt, SR Setlur, ...
Oncogene 26 (31), 4596-4599, 2007
Mandates: German Research Foundation
Review
The long tail of oncogenic drivers in prostate cancer
J Armenia, SAM Wankowicz, D Liu, J Gao, R Kundra, E Reznik, ...
Nature genetics 50 (5), 645-651, 2018
Mandates: US National Institutes of Health, V Foundation, USA
Review
TMPRSS2: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
S Perner, F Demichelis, R Beroukhim, FH Schmidt, JM Mosquera, S Setlur, ...
Cancer research 66 (17), 8337-8341, 2006
Mandates: German Research Foundation
Review
Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study
R Aggarwal, J Huang, JJ Alumkal, L Zhang, FY Feng, GV Thomas, ...
Journal of Clinical Oncology 36 (24), 2492, 2018
Mandates: US National Institutes of Health
Review
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
N Palanisamy, B Ateeq, S Kalyana-Sundaram, D Pflueger, ...
Nature medicine 16 (7), 793-798, 2010
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
Publication and funding information is determined automatically by a computer program